Crossmark

Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?

Crossref DOI link: https://doi.org/10.1038/s41436-018-0301-4

Published Print: 2019-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Witters, Peter

Honzik, Tomas

Bauchart, Eric

Altassan, Ruqaiah

Pascreau, Tiffany

Bruneel, Arnaud

Vuillaumier, Sandrine

Seta, Nathalie

Borgel, Delphine

Matthijs, Gert

Jaeken, Jaak

Meersseman, Wouter

Cassiman, David

Pascale de, Lonlay

Morava, Eva
License Information

Text and Data Mining valid from 2019-05-01

Text and Data Mining valid from 2019-05-01

Version of Record valid from 2022-01-19
More Information

This article is maintained by: Elsevier

Article Title: Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?

Journal Title: Genetics in Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41436-018-0301-4

Content Type: article

Copyright: © 2019, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics